U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C7H4ClNO2
Molecular Weight 169.565
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CHLORZOXAZONE

SMILES

ClC1=CC=C2OC(=O)NC2=C1

InChI

InChIKey=TZFWDZFKRBELIQ-UHFFFAOYSA-N
InChI=1S/C7H4ClNO2/c8-4-1-2-6-5(3-4)9-7(10)11-6/h1-3H,(H,9,10)

HIDE SMILES / InChI
Molecular Formula C7H4ClNO2
Molecular Weight 169.565
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Sat Dec 16 05:13:25 UTC 2023
Edited
by admin
on Sat Dec 16 05:13:25 UTC 2023
Record UNII
H0DE420U8G
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CHLORZOXAZONE
INN   JAN   MART.   MI   ORANGE BOOK   USP   USP-RS   VANDF   WHO-DD  
INN  
Official Name English
CHLORZOXAZONE [MART.]
Common Name English
chlorzoxazone [INN]
Common Name English
Chlorzoxazone [WHO-DD]
Common Name English
CHLORZOXAZONE [USP-RS]
Common Name English
5-Chloro-2-benzoxazolinone
Systematic Name English
STRIFON
Brand Name English
CHLORZOXAZONE [JAN]
Common Name English
CHLORZOXAZONE [USP IMPURITY]
Common Name English
PARAFLEX
Brand Name English
CHLORZOXAZONE [MI]
Common Name English
CHLORZOXAZONE [ORANGE BOOK]
Common Name English
PARAFON
Brand Name English
CHLORZOXAZONE [VANDF]
Common Name English
CHLORZOXAZONE [USP MONOGRAPH]
Common Name English
2(3H)-BENZOXAZOLONE, 5-CHLORO-
Systematic Name English
Classification Tree Code System Code
LIVERTOX NBK548137
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
NDF-RT N0000175737
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
WHO-VATC QM03BB53
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
WHO-ATC M03BB03
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
WHO-VATC QM03BB03
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
WHO-ATC M03BB53
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
NDF-RT N0000175730
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
WHO-ATC M03BB73
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
NCI_THESAURUS C29696
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
WHO-VATC QM03BB73
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
Code System Code Type Description
ECHA (EC/EINECS)
202-403-9
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
PRIMARY
EPA CompTox
DTXSID9022813
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
PRIMARY
MESH
D002753
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
PRIMARY
FDA UNII
H0DE420U8G
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
PRIMARY
DAILYMED
H0DE420U8G
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
PRIMARY
IUPHAR
2322
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
PRIMARY
CAS
95-25-0
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
PRIMARY
EVMPD
SUB06215MIG
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
PRIMARY
WIKIPEDIA
CHLORZOXAZONE
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
PRIMARY
RXCUI
2410
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
PRIMARY RxNorm
ChEMBL
CHEMBL1371
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
PRIMARY
CHEBI
3655
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
PRIMARY
INN
748
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
PRIMARY
MERCK INDEX
m3471
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
PRIMARY Merck Index
RS_ITEM_NUM
1130505
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
PRIMARY
SMS_ID
100000081896
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
PRIMARY
NCI_THESAURUS
C28926
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
PRIMARY
DRUG CENTRAL
626
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
PRIMARY
PUBCHEM
2733
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
PRIMARY
DRUG BANK
DB00356
Created by admin on Sat Dec 16 05:13:25 UTC 2023 , Edited by admin on Sat Dec 16 05:13:25 UTC 2023
PRIMARY
Related Record Type Details
PLASMA PROTEIN FRACTION (HUMAN)
BINDER->LIGAND
BINDING
CYTOCHROME P450 2E1
METABOLIC ENZYME -> SUBSTRATE
Structure of CHLORZOXAZONE
EXCRETED UNCHANGED
Related Record Type Details
Structure of 6-HYDROXYCHLORZOXAZONE GLUCURONIDE
METABOLITE INACTIVE -> PARENT
MAJOR
URINE
Structure of 6-HYDROXYCHLORZOXAZONE
METABOLITE -> PARENT
further metabolized to glucoronide
MAJOR
PLASMA
Related Record Type Details
Structure of CHLORZOXAZONE
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Volume of Distribution PHARMACOKINETIC
Biological Half-life PHARMACOKINETIC
Cmax PHARMACOKINETIC ROUTE OF ADMINISTRATION
PHARMACOKINETIC
DOSE
PHARMACOKINETIC
Tmax PHARMACOKINETIC ROUTE OF ADMINISTRATION
PHARMACOKINETIC
DOSE
PHARMACOKINETIC
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966